Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:57 AM UTC
| NCT Number | NCT02478892 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | February 5, 2026 (Feb 5, 2026) |
As of July 18, 2026: Clinical trial NCT02478892 is currently recruiting participants. This clinical trial study for pancreatic cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02478892 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02478892 was last updated Feb 5, 2026 (February 5, 2026). HelloStudys verifies this status automatically.